Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of
multiple doses of an experimental hepatitis C virus (HCV) protease inhibitor with ritonavir
in healthy volunteers.